Diamond Biotechnology Co., Ltd (TPEX:6815)

Diamond Biotechnology Revenue

Diamond Biotechnology had revenue of 280.74M TWD in the half year ending June 30, 2026, a decrease of -27.60%. This brings the company's total for the last twelve months to 464.63M, down -33.45% year-over-year. In the year 2025, Diamond Biotechnology had annual revenue of 501.49M, down -34.72%. That makes Diamond Biotechnology the 35,664th largest company in the world by revenue and 1,856th in Taiwan.

• Revenue (ttm): 464.63M
• Revenue Growth: -33.45%
• P/S Ratio: 1.79
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 831.82M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 434.23M 86.6%
• Mainland China 67.27M 13.4%

Fiscal year ended Dec 31, 2025 See the full Diamond Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	501.49M	-266.76M	-34.72%
Dec 31, 2024	768.25M	152.16M	24.70%
Dec 31, 2023	616.10M	181.25M	41.68%
Dec 31, 2022	434.84M	39.64M	10.03%
Dec 31, 2021	395.20M	88.81M	28.99%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 29, 2026

Data Sources Report a data error